Investing.com -- Bernstein analysts say the market has overreacted to President Trump’s latest executive order on drug ...

Investing.com -- Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares tumbled 10.7% after the neuroscience-focused biopharmaceutical company reported first quarter earnings and announced a delay in ...

Halozyme Therapeutics (NASDAQ: HALO) shares fell sharply by 16% after Leerink Partners analyst David Risinger downgraded the stock from Market Perform to Underper ...

CompoSecure posted adjusted earnings per share of -$0.07 for the quarter, falling short of analyst estimates of $0.19. Revenue came in at $103.9 million, marginally above the consensus forecast of ...

For Q1 2025, Nayax posted adjusted earnings per share of $0.19, significantly beating the analyst consensus of $0.02. However, revenue came in at $81.1 million, missing the $85.08 million estimate.

James has initiated coverage on Super Micro Computer (NASDAQ: SMCI) with an Outperform rating and a $41 price target, highlighting the company ...